CHARLES RIVER LABORATORIES (CRL)       228.57  -10.93 (-4.56%)

Which S&P500 stocks are moving on Wednesday?

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Wednesday Sector Laggards: Healthcare, Energy

CRL stock drops after disclosing supply challenges for animal studies (NYSE:CRL)

Charles River Laboratories (CRL) was among notable decliners in the S&P 500 on Wednesday after the non-clinical contract research organization announced that a recent DoJ indictment...

Top S&P500 movers in Wednesday's session

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program

Charles River Laboratories to Present at November Investor Conferences

Bullish Two Hundred Day Moving Average Cross - CRL

Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022

Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients

S&P 500 Movers: EXR, MTCH

Why Charles River Laboratories Stock Is Jumping Today

Investors liked the company's Q3 update.

Charles River Laboratories Announces Third-Quarter 2022 Results

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

S&P 500 Movers: BRO, CRL

Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership

Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call

Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs

S&P 500 Analyst Moves: CRL

S&P 500 Movers: CCL, CRL

Charles River Laboratories International Becomes Oversold (CRL)

First Week of May 2023 Options Trading For Charles River Laboratories International (CRL)

Annaly Capital Management Larger Than S&P 500 Component Charles River Laboratories International

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration